Karla Moya-Crites
Family Medicine · Santa Fe, NMNPI 1649742966
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 159 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $991 and has fallen 82.9% since, to $169 in 2025. Among family medicine clinicians in NM with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 159 payments — averaging $16.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$558
- AbbVie$455
- AstraZeneca$348
- Lilly USA, LLC$235
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$180
- Sanofi-aventis U.S. LLC$145
- plus $735 from 17 others
What the payments were for
- Food & beverage$2,63999%
- Education$161%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 30 | $558 |
| AbbVie | 34 | $455 |
| AstraZeneca | 21 | $348 |
| Lilly USA, LLC | 13 | $235 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $180 |
| Sanofi-aventis U.S. LLC | 9 | $145 |
| Pfizer | 7 | $142 |
| Boehringer Ingelheim | 7 | $131 |
| Organon | 6 | $84 |
| Nestle Healthcare Nutrition Inc. | 4 | $59 |
| GSK | 3 | $46 |
| Dexcom, Inc. | 2 | $40 |
| E.r. Squibb & Sons, L.L.C. | 2 | $32 |
| Merck | 2 | $31 |
| Astellas Pharma US Inc | 1 | $30 |
| Biohaven Pharmaceuticals, Inc. | 1 | $23 |
| Amarin Pharma, Inc. | 1 | $21 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $19 |
| Novo Nordisk | 1 | $17 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
| Exact Sciences | 1 | $16 |
| Johnson & Johnson | 1 | $13 |
| Smith+Nephew | 1 | $13 |
How this compares
$2,655 in reported general payments places this provider in the 90th percentile of 717 family medicine providers in New Mexico.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 38 | $37,066 |
| OzempicSemaglutide | 23 | $35,304 |
| JardianceEmpagliflozin | 36 | $31,510 |
| FarxigaDapagliflozin Propanediol | 37 | $26,260 |
| RybelsusSemaglutide | 13 | $19,259 |
| MounjaroTirzepatide | 12 | $14,005 |
| EliquisApixaban | 12 | $13,543 |
| XareltoRivaroxaban | 13 | $8,454 |
| LinzessLinaclotide | 11 | $5,736 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 113 | $3,782 |
| Dexlansoprazole DrDexlansoprazole | 15 | $3,239 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 58 | $1,504 |
| Omeprazole | 72 | $1,386 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 14 | $1,299 |
| Atorvastatin Calcium | 116 | $1,285 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $17 | $54,56336 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $235 | $51,07050 claims |
| Boehringer IngelheimJardiance | $131 | $31,51036 claims |
| AstraZenecaFarxiga | $348 | $26,26037 claims |
| PfizerEliquis | $142 | $13,54312 claims |
| Johnson & JohnsonXarelto | $13 | $8,45413 claims |
| AbbVieLinzess | $455 | $5,73611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 717 family medicine providers in New Mexico.
Other family medicine in Santa Fe
- Wendy JohnsonSanta Fe$37K
- Kurt KastendieckSanta Fe$7K
- Carl FriedrichsSanta Fe$7K
- Luis Rigales IiiSanta Fe$4K
- Aryan CaireSanta Fe$3K
- Debra HigginbothamSanta Fe$3K
- Gerzain ChavezSanta Fe$3K
- Harold McFarlingFarmington$160K
- Carletta BullockAlbuquerque$60K
- Robert BairAlbuquerque$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.